Remdesivir Intermediate CAS 1770840-43-1 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine COVID-19
Onye nrụpụta Azụmahịa Remdesivir na ihe ndị metụtara ya nwere ogo dị elu
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy) (phenoxy) phosphoryl) -L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy) phenoxyphosfinyl] -L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S) -2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Metabolite Remdesivir (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermediate CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Aha Chemical | 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine |
Ụdị okwu | 7-Iodopyrrolo [2,1-f][1,2,4]triazin-4-amine;Remdesivir-004;Remdesivir adịghị ọcha 30 |
Nọmba CAS | 1770840-43-1 |
Nọmba CAT | RF-PI304 |
Ọnọdụ Ahịa | Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms |
Usoro ihe omimi | C6H5IN4 |
Ibu molekụla | 260.04 |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Agba odo na ntụ ntụ ntụ ntụ |
Spectrum infrared | Dabara na Ọdịdị |
Ịdị ọcha | ≥98.0% (HPLC) |
Ọnwụ na ihicha | ≤0.50% |
Otu adịghị ọcha | ≤0.50% |
Ọla dị arọ | ≤20ppm |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ọkara nke Remdesivir (CAS 1809249-37-3) |
ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine (CAS 1770840-43-1) bụ etiti nke Remdesivir (CAS 1809249-37-3).Remdesivir bụ ọgwụ mgbochi nje eji egbochi ọrụ RNA polymerase.A nyochara Remdesivir na mbụ dịka ọgwụgwọ maka nje Ebola, mana ọ nwere ike ịgwọ ụdị nje RNA dị iche iche.A kọwara ọrụ ya megide ezinụlọ coronavirus (CoV) nke nje, dị ka SARS-CoV na MERS-CoV, na 2017, a na-enyochakwa ya dị ka ọgwụgwọ nwere ike ibute ọrịa SARS-CoV-2.